CatalystFDA/Bio

Pfizer says phase 3 data buoys Litfulo as a vitiligo treatment

Pfizer reports positive phase 3 data for Litfulo in vitiligo treatment.

What changed

Pfizer reports positive phase 3 data for Litfulo in vitiligo treatment.

Why it matters

Pfizer reports positive phase 3 data for Litfulo in vitiligo treatment. — impact context not separately stored; see What changed.

Sources